A Century-Old Legacy at Risk: The Untold Story of Bengal’s Ayurvedic Pioneer
In the heart of Gandaria, Dhaka, within the unassuming walls of a large factory at 71 Dinanath Sen Road, a man sat hunched over a desk, illuminated only by the faint glow of a 40-watt bulb. Jogesh Chandra Ghosh, wrapped in a thin shawl with his dhoti pulled up to his knees, was penning a formula for a new medicine. His appearance belied his wealth; few would have guessed he was a millionaire. But this was no ordinary entrepreneur—this was the visionary behind Shadhana Oushadhalaya, a name that would become synonymous with Ayurvedic excellence across India and beyond.
But here's where it gets controversial... While Shadhana Oushadhalaya flourished in the '50s and '60s, boasting over 150 branches and 2,000 agencies across India, its decline in the '90s raises a provocative question: Did the rise of modern medicine unfairly overshadow Ayurveda, or did Ayurveda fail to adapt to changing times? Let’s delve into this remarkable story.
By the mid-20th century, Shadhana’s medicines were in high demand, particularly in Bihar and Assam. Jogesh Babu, as he was affectionately known, even harbored ambitions to expand into Europe and America. His dedication was recognized by none other than Acharya Prafulla Chandra Ray, who, during a visit to Dhaka, marveled at the piles of international orders flooding Shadhana’s factory. Yet, despite this success, the tide began to turn with the advent of technological advancements and the growing popularity of allopathic medicine.
And this is the part most people miss... Chittaranjan Das, the retail branch manager of Shadhana Oushadhalaya, reflects, “Shadhana was a household name until the '90s. But as technology advanced, people drifted away from Ayurveda. The upper classes, once loyal to Ayurvedic treatments, suddenly switched to allopathy. Yet, we still have customers who’ve trusted us for generations. It’s their loyalty that keeps us going.” This shift wasn’t just a matter of preference—it was a cultural and economic transformation that Ayurveda struggled to navigate.
Jogesh Babu’s journey into Ayurveda began in his college days. After completing his BA in 1906, he pursued his MA at the University of Calcutta, where Acharya Ray inspired him to harness indigenous resources for medicine. This resonated deeply with the Swadeshi movement, which, following the 1905 Partition of Bengal, advocated for boycotting foreign goods and promoting local alternatives. For Jogesh Babu, Ayurveda wasn’t just a medical system—it was a way to serve humanity and a patriotic duty.
In 1908, he traveled to England and later to America for advanced studies in chemistry. Upon returning, he immersed himself in Ayurveda, spending four years studying it extensively while teaching at Bhagalpur College. This dual focus on modern science and ancient wisdom became the cornerstone of his approach to medicine.
A Bold Interpretation: Was Ayurveda’s Decline Inevitable? Some argue that Ayurveda’s decline was inevitable in the face of modern medicine’s rapid advancements. Others contend that it was a failure of marketing and adaptation. What do you think? Could Ayurveda have thrived if it had embraced modern scientific validation earlier?
By 1914, Jogesh Babu established Shadhana Oushadhalaya in Gandaria, initially as a small research lab. By 1917, it had grown into a full-scale factory, producing medicines with electric machinery. Each branch offered affordable consultations by experienced Kavirajes or Vaidyas, and innovations like Sadhanadashan tooth powder and Shri Gopal Tel oil became household staples.
Jogesh Babu’s patriotism was unwavering. He wrote, “Shadhana is the dearest institution of my life, but when a business serves the greater good of the nation, it transcends personal welfare.” His dedication was acknowledged by leaders like Netaji Subhas Chandra Bose, who praised Shadhana’s philanthropic approach and commitment to Ayurveda.
A Thought-Provoking Question: Can Ayurveda Compete in Today’s World? With India’s Ayurvedic market booming—from $2.85 billion in 2014 to $10.5 billion in 2024—Shadhana’s legacy seems more relevant than ever. Yet, the company’s struggles today raise questions about the sustainability of traditional businesses in a modern economy. Can Ayurveda strike a balance between tradition and innovation?
Jogesh Babu’s martyrdom during the Bangladesh Liberation War further cemented his legacy. Despite pleas from his family, he refused to leave Dhaka, declaring, “If I have to die, I will die on the soil of this country.” On April 4, 1971, he was brutally murdered by the Pakistani Army, a sacrifice honored by Bangladesh with a commemorative stamp in 1991.
Today, Shadhana Oushadhalaya survives, but its challenges are mounting. With over a hundred branches in India and annual earnings of 1.5 to 2 crore rupees, it still serves its loyal customers. However, the number of medicines produced has dwindled from 450 to just 120, and exports have nearly halted due to high costs and logistical hurdles. The company’s future is uncertain, with its only heir, Sheela, showing little interest in continuing the business. “What will we do with more money? Who will use it? It’s better to see how much we can help people,” she says, echoing her grandfather’s humanitarian spirit.
Final Question for You: Is Ayurveda’s Future at Risk, or Can It Be Revived? As we reflect on Shadhana’s 111-year legacy, the question remains: Can Ayurveda reclaim its place in a world dominated by modern medicine? Share your thoughts in the comments—let’s spark a conversation about the future of this ancient science.
